Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study

Figure 3

Percentage of participants in the ACWY-TT and Men-PS groups experiencing solicited local and general symptoms( total vaccinated cohort). ACWY-TT = group of participants who received one dose of MenACWY-TT at Month 0. Men-PS = group of participants who received one dose of the MenACWY polysaccharide vaccine at Month 0.% = percentage of participants with at least once the symptom within the four-day post-vaccination period (total vaccinated cohort). Error bars represent 95% confidence intervals.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us